JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2005; 46:2258-2263, doi:10.1016/j.jacc.2005.04.067
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ermis, C.
Right arrow Articles by Benditt, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ermis, C.
Right arrow Articles by Benditt, D. G.

CLINICAL RESEARCH: ARRHYTHMIAS, RIGHT VENTRICULAR FUNCTION, AND MITRAL REGURGITATION

Impact of Upgrade to Cardiac Resynchronization Therapy on Ventricular Arrhythmia Frequency in Patients With Implantable Cardioverter-Defibrillators

Cengiz Ermis, MD*, Ryan Seutter, MD*, Alan X. Zhu, MD*, Lauren C. Benditt, BA*, Laura VanHeel, RN{dagger}, Scott Sakaguchi, MD, FACC*,{dagger}, Keith G. Lurie, MD, FACC*,{dagger}, Fei Lu, MD, PhD*,{dagger} and David G. Benditt, MD, FACC*,{dagger},*

* Cardiac Arrhythmia Center, University of Minnesota Medical School, Minneapolis, Minnesota
{dagger} Central Minnesota Heart Center, St. Cloud Hospital, St. Cloud, Minnesota.

Manuscript received March 13, 2005; revised manuscript received April 2, 2005, accepted April 13, 2005.

* Reprint requests and correspondence: Dr. David G. Benditt, MMC 508, University of Minnesota Hospital-Fairview, 420 Delaware Street SE, Minneapolis, Minnesota 55455. (Email: bendi001{at}umn.edu).

OBJECTIVES: This study compared cardiac resynchronization therapy’s (CRT) impact on ventricular tachyarrhythmia susceptibility in patients who, due to worsening heart failure (HF) symptoms, underwent a replacement of a conventional implantable cardioverter-defibrillator (ICD) with a CRT-ICD.

BACKGROUND: Cardiac resynchronization therapy is an effective addition to conventional treatment of HF in many patients with left ventricular systolic dysfunction. However, whether CRT-induced improvements in HF status also reduce susceptibility to life-threatening arrhythmias is less certain.

METHODS: Clinical and ICD electrogram data were evaluated in 18 consecutive ICD patients who underwent an upgrade to CRT-ICD. Pharmacologic HF therapy was not altered during follow-up. The definition of ventricular tachycardia (VT) and ventricular fibrillation (VF) for each patient was as determined by device programming. Statistical comparisons used paired t tests.

RESULTS: Findings were recorded during two time periods: 47 ± 21 months (range 24 to 70 months) before and 14 ± 2 months (range 9 to 18 months) after CRT upgrade. At time of upgrade, patient age was 69 ± 11 years and ejection fraction was 21 ± 8%. Before CRT the frequency of VT, VF, and appropriate ICD shocks was 0.31 ± 1.23, 0.047 ± 0.083, and 0.048 ± 0.085 episodes/month/patient, respectively. After CRT-ICD, VT and VF arrhythmia burdens and frequency of shocks were respectively 0.13 ± 0.56, 0.001 ± 0.004, and 0.003 ± 0.016 episodes/month/patient (p = 0.59, 0.03, and 0.05 vs. pre-CRT).

CONCLUSIONS: Arrhythmia frequency and number of appropriate ICD treatments were reduced after upgrade to CRT-ICD for HF treatment. Thus, apart from hemodynamic benefits, CRT may also ameliorate ventricular tachyarrhythmia susceptibility in HF patients.

Abbreviations and Acronyms
  ATP = antitachycardia pacing
  CARE-HF = Cardiac Resynchronization Heart Failure trial
  COMPANION = Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure trial
  CRT = cardiac resynchronization therapy
  HF = heart failure
  ICD = implantable cardioverter-defibrillator
  LVEF = left ventricular ejection fraction
  MIRACLE = Multicenter InSync Randomized Clinical Evaluation trial
  NYHA = New York Heart Association
  VF = ventricular fibrillation
  VT = ventricular tachycardia




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
D. G. Benditt, D. Yannopoulos, K. G. Lurie, S. Sakaguchi, L. Van Heel, S. Milstein, and C. Ermis
Reply.
J. Am. Coll. Cardiol., February 12, 2008; 51(6): 677 - 677.
[Full Text] [PDF]


Home page
HeartHome page
G Lin, R F Rea, S C Hammill, D L Hayes, and P A Brady
Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices
Heart, February 1, 2008; 94(2): 186 - 190.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C. Leclercq
Upgrading from right ventricular pacing to biventricular pacing in pacemaker patients with chronic heart failure
Heart, January 1, 2008; 94(1): 102 - 107.
[Full Text] [PDF]


Home page
BMJHome page
F. A McAlister
Device therapy in heart failure
BMJ, November 3, 2007; 335(7626): 895 - 896.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Yannopoulos, K. G. Lurie, S. Sakaguchi, S. Milstein, C. Ermis, L. VanHeel, and D. G. Benditt
Reduced Atrial Tachyarrhythmia Susceptibility After Upgrade of Conventional Implanted Pulse Generator to Cardiac Resynchronization Therapy in Patients With Heart Failure
J. Am. Coll. Cardiol., September 25, 2007; 50(13): 1246 - 1251.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
F. A. McAlister, J. Ezekowitz, N. Hooton, B. Vandermeer, C. Spooner, D. M. Dryden, R. L. Page, M. A. Hlatky, and B. H. Rowe
Cardiac Resynchronization Therapy for Patients With Left Ventricular Systolic Dysfunction: A Systematic Review
JAMA, June 13, 2007; 297(22): 2502 - 2514.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. D. Burkhardt and B. L. Wilkoff
Interventional Electrophysiology and Cardiac Resynchronization Therapy: Delivering Electrical Therapies for Heart Failure
Circulation, April 24, 2007; 115(16): 2208 - 2220.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
B. K. Kantharia, J. A. Patel, B. S. Nagra, and G. S. Ledley
Electrical storm of monomorphic ventricular tachycardia after a cardiac-resynchronization-therapy-defibrillator upgrade
Europace, August 1, 2006; 8(8): 625 - 628.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
C. Ermis and D. G. Benditt
Cardiac resynchronization pacing without defibrillator capability: is this a viable option?
Europace, July 1, 2006; 8(7): 499 - 501.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2005 by the American College of Cardiology Foundation.